GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Il10 | decreases abundance | EXP | | 152995414 | RGD | 2,4,6-trinitrobenzenesulfonic acid decreases abundance of IL-10 protein in rat colon | | Il10 | decreases expression | EXP | | 6480464 | CTD | Trinitrobenzenesulfonic Acid results in decreased expression of IL10; Trinitrobenzenesulfonic Acid results in decreased expression of IL10 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein | PMID:15604057 PMID:16867261 PMID:24316276 PMID:25727887 PMID:33412153 | Il10 | decreases secretion | EXP | | 6480464 | CTD | Trinitrobenzenesulfonic Acid results in decreased secretion of IL10 protein | PMID:25729217 | Il10 | increases expression | EXP | | 6480464 | CTD | Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein | PMID:24831514 PMID:30365937 PMID:35290143 | Il10 | multiple interactions | EXP | | 6480464 | CTD | [iberogast analog co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 mRNA; [iberogast co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 mRNA; bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 mRNA]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein]; Isatin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein] | PMID:15604057 PMID:16867261 PMID:19196500 PMID:24316276 PMID:24831514 PMID:25727887 PMID:30365937 PMID:33412153 PMID:35290143 | Il10 | decreases expression | ISO | Il10 (Mus musculus) | 6480464 | CTD | Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein | PMID:22060784 | Il10 | increases expression | ISO | Il10 (Mus musculus) | 6480464 | CTD | Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA | PMID:11717450 PMID:15973123 PMID:17375199 PMID:21829567 PMID:25307695 | Il10 | multiple interactions | ISO | Il10 (Mus musculus) | 6480464 | CTD | [cholan-2,3,24-tryl-2,3,24-trisulfate co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 protein; [rifaximin co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 protein; seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; soyasaponin Ab inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein] | PMID:11717450 PMID:21599020 PMID:22060784 | |
Go Back to source page | Continue to Ontology report |